Repurposing clemastine to target glioblastoma cell stemness
M. A. Sun, R. Yang, H. Liu…·Y. He
This study shows clemastine, an antihistamine, reduces glioblastoma stemness by targeting EBP, a cholesterol pathway enzyme, and promotes differentiation of oligodendrocyte progenitor cells.